Literature DB >> 24715485

Neurocognitive assessment in the diagnosis of HIV-associated neurocognitive disorders.

Kevin Robertson1, Sarah Yosief1.   

Abstract

Neurocognitive assessment plays a central role in the diagnosis of human immunodeficiency virus- (HIV) associated neurocognitive disorders (HAND). The history of diagnostic categories and labeling of HIV-related neurological disorders is briefly presented. The current diagnostic nomenclature of HAND and the role of neurocognitive assessment is examined. Though neurocognitive testing is sensitive in assessing a broad range of cognitive impairments, neurocognitive testing is not specific to HAND without consideration of the impact on functional status, as well as confounding factors, including premorbid status. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2014        PMID: 24715485     DOI: 10.1055/s-0034-1372339

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  18 in total

1.  Soluble membrane attack complex in the blood and cerebrospinal fluid of HIV-infected individuals, relationship to HIV RNA, and comparison with HIV negatives.

Authors:  Albert M Anderson; Theresa N Schein; Aley Kalapila; Lillin Lai; Drenna Waldrop-Valverde; Raeanne C Moore; Donald Franklin; Scott L Letendre; Scott R Barnum
Journal:  J Neuroimmunol       Date:  2017-07-23       Impact factor: 3.478

2.  Manganese-Enhanced Magnetic Resonance Imaging Reflects Brain Pathology During Progressive HIV-1 Infection of Humanized Mice.

Authors:  Aditya N Bade; Santhi Gorantla; Prasanta K Dash; Edward Makarov; Balasrinivasa R Sajja; Larisa Y Poluektova; Jiangtao Luo; Howard E Gendelman; Michael D Boska; Yutong Liu
Journal:  Mol Neurobiol       Date:  2015-06-11       Impact factor: 5.590

3.  The nature and consequences of cognitive deficits among tobacco smokers with HIV: a comparison to tobacco smokers without HIV.

Authors:  Joseph D Harrison; Jessica A Dochney; Sonja Blazekovic; Frank Leone; David Metzger; Ian Frank; Robert Gross; Anita Hole; Karam Mounzer; Steven Siegel; Robert A Schnoll; Rebecca L Ashare
Journal:  J Neurovirol       Date:  2017-04-20       Impact factor: 2.643

4.  Single-cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid during virologically suppressed HIV.

Authors:  Shelli F Farhadian; Sameet S Mehta; Chrysoula Zografou; Kevin Robertson; Richard W Price; Jenna Pappalardo; Jennifer Chiarella; David A Hafler; Serena S Spudich
Journal:  JCI Insight       Date:  2018-09-20

5.  Preliminary study of a novel cognitive assessment device for the evaluation of HIV-associated neurocognitive impairment.

Authors:  Albert M Anderson; Jeffrey L Lennox; Minh L Nguyen; Drenna Waldrop-Valverde; William R Tyor; David W Loring
Journal:  J Neurovirol       Date:  2016-05-31       Impact factor: 2.643

6.  Cerebrospinal fluid interferon alpha levels correlate with neurocognitive impairment in ambulatory HIV-Infected individuals.

Authors:  Albert M Anderson; Jeffrey L Lennox; Mark M Mulligan; David W Loring; Henrik Zetterberg; Kaj Blennow; Cari Kessing; Rajeth Koneru; Kirk Easley; William R Tyor
Journal:  J Neurovirol       Date:  2016-07-11       Impact factor: 2.643

Review 7.  Bidirectional Associations among Nicotine and Tobacco Smoke, NeuroHIV, and Antiretroviral Therapy.

Authors:  Shivesh Ghura; Robert Gross; Kelly Jordan-Sciutto; Jacob Dubroff; Robert Schnoll; Ronald G Collman; Rebecca L Ashare
Journal:  J Neuroimmune Pharmacol       Date:  2019-12-13       Impact factor: 4.147

8.  Neurofilament light chain in blood is negatively associated with neuropsychological performance in HIV-infected adults and declines with initiation of antiretroviral therapy.

Authors:  Albert M Anderson; Kirk A Easley; Nicole Kasher; Donald Franklin; Robert K Heaton; Henrik Zetterberg; Kaj Blennow; Magnus Gisslen; Scott L Letendre
Journal:  J Neurovirol       Date:  2018-08-13       Impact factor: 2.643

9.  Cognitive and Neuronal Link With Inflammation: A Longitudinal Study in People With and Without HIV Infection.

Authors:  Albert M Anderson; Jeong Hoon Jang; Kirk A Easley; Dietmar Fuchs; Magnus Gisslen; Henrik Zetterberg; Kaj Blennow; Ronald J Ellis; Donald Franklin; Robert K Heaton; Igor Grant; Scott L Letendre
Journal:  J Acquir Immune Defic Syndr       Date:  2020-12-15       Impact factor: 3.731

10.  Distinct cellular immune properties in cerebrospinal fluid are associated with cognition in HIV-infected individuals initiating antiretroviral therapy.

Authors:  Beret Amundson; Lillin Lai; Mark J Mulligan; Yong Xu; Zidou Zheng; Suprateek Kundu; Jeffrey L Lennox; Drenna Waldrop-Valverde; Donald Franklin; Alison Swaims-Kohlmeier; Scott L Letendre; Albert M Anderson
Journal:  J Neuroimmunol       Date:  2020-04-27       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.